Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Psychiatric Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpsychires.2013.10.011PMID 24231512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacy and Pharmaceutical Sciences

  2015cited by this paper
• Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa.

  2013cited by this paper
• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

  2013cited by this paper
• Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.

  2012cited by this paper
• Cognitive Aspects of Depression.

  2012cited by this paper
• Nanostructure-based drug delivery systems for brain targeting

  2012cited by this paper
• Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine

  2011cited by this paper
• Neurotherapeutic applications of nanoparticles in Alzheimer's disease.

  2011cited by this paper
• Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

  2011cited by this paper
• Potential of nanoparticulate drug delivery systems by intranasal administration.

  2010cited by this paper
• Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.

  2010cited by this paper
• Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010influential reference
• Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats

  2010cited by this paper
• Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses

  2010cited by this paper
• Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery

  2010cited by this paper
• Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats

  2009cited by this paper
• Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009cited by this paper
• Relationship of neurotransmitters to the symptoms of major depressive disorder.

  2008cited by this paper
• Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

  2008cited by this paper
• The neglected ‘m’ in MCH programmes – why mental health of mothers is important for child nutrition

  2008cited by this paper
• Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

  2008cited by this paper
• Implications of ATP-binding cassette transporters for brain pharmacotherapies.

  2007cited by this paper
• Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series.

  2007cited by this paper
• Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.

  2007cited by this paper
• Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.

  2007cited by this paper
• Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

  2007cited by this paper
• Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

  2007cited by this paper
• Monolithic gelation of chitosan solutions via enzymatic hydrolysis of urea

  2006cited by this paper
• Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies

  2006cited by this paper
• Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.

  2006cited by this paper
• SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

  2005cited by this paper
• Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke

  2005cited by this paper
• Drug resistance in brain diseases and the role of drug efflux transporters

  2005cited by this paper
• Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.

  2005cited by this paper
• Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.

  2005cited by this paper
• Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

  2005cited by this paper
• Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.

  2005cited by this paper
• Metabolism and elimination of rhodamine 123 in the rat

  2004cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Neurology of the Arts: Painting, Music, Literature

  2004cited by this paper
• Potential new drug delivery systems for antidepressants: an overview.

  2003cited by this paper
• Neuropsychopharmacology : The Fifth Generation of Progress

  2002cited by this paper
• Assessing antidepressant activity in rodents: recent developments and future needs.

  2002cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper
• The burden of recurrent depression: causes, consequences, and future prospects.

  2001cited by this paper
• Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

  2001cited by this paper
• Delivery of Neurotrophic Factors to the Central Nervous System

  2001cited by this paper
• Current Protocols In Neuroscience

  1999cited by this paper
• Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration

  1999cited by this paper
• BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123

  1998cited by this paper
• Adv. Drug Delivery Rev.

  1997cited by this paper
• Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study

  1996cited by this paper
• Tissue distribution of the multidrug resistance protein.

  1996cited by this paper
• The Pharmacokinetics of Venlafaxine When Given in a Twice‐Daily Regimen

  1995cited by this paper
• Optimization of theophylline release from tablets containing Compritol

  1995cited by this paper
• Development of a new drug carrier made from alginate.

  1993cited by this paper
• Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

  1986cited by this paper
• Endocytic and exocytic pathways of the neuronal secretory process and trans synaptic transfer of wheat germ agglutinin‐horseradish peroxidase in vivo

  1985cited by this paper
• Comparative morphometry of the nasal cavity in rats and mice.

  1982cited by this paper
• Effects of antidepressants in the rat forced swimming test.

  1981cited by this paper
• "Behavioural despair" in rats and mice: strain differences and the effects of imipramine.

  1978cited by this paper

• Evaluation of antioxidant, anti-inflammatory, analgesic, and antidepressant activities of different extracts from Ammodaucus leucotrichus

  2026cites this paper
• Development of Nose-to-Brain Targeted Cow Milk-Derived Exosomes for Enhanced Delivery of Curcumin to the Brain

  2026influential citation
• Emerging use of bio-nanomaterials for brain pathologies.

  2026cites this paper
• From detection to drug delivery: innovations in cancer biosensors from concept to clinical impact

  2025cites this paper
• Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer’s disease

  2025cites this paper
• The Heart–Brain Axis in the Artificial Intelligence Era: Integrating Old and New Insights Towards New Targeting and Innovative Neuro- and Cardio-Therapeutics

  2025cites this paper
• Investigating the potential of quercetin-loaded chitosan-coated lipid carriers as an oral nanoplatform for depression management.

  2025cites this paper
• Advancements in Nanotherapeutics for the Treatment of Depression via Intranasal Pathway: A Review

  2025cites this paper
• Nasal-to-brain delivery of CCR5 antagonist for reshaping the dysregulated microglia-neuron axis and enhancing post-traumatic cognitive function.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Design and evaluation of carnosic acid-loaded thermosensitive lipidic nanogels for nasal delivery: ex vivo permeation, nasal ciliotoxicity, and antioxidant assessment

  2025cites this paper
• Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview

  2025cites this paper
• A Dual Nanoapproach for the Treatment of Depression and Sleep Via a Novel Optimized Eugenol-Mucoadhesive Nanoemulsion

  2025cites this paper
• Design and optimization of venlafaxine niosomes loaded thermosensitive in-situ gel for prolonging intranasal residence in depressive disorder

  2025cites this paper
• Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model.

  2025cites this paper
• Intranasal Poly(Lactic-co-Glycolic Acid) Nanoparticles of Mefenamic Acid Improve Motor Expressions and Neurochemical Injury in Aluminium Chloride Originated Alzheimer’s Disease

  2025cites this paper
• Intranasal Delivery of Kaempferol via Magnesomes for Brain Seizure Treatment: Design, Characterization, and Biodistribution Studies.

  2025cites this paper
• Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: in vitro, ex vivo, and in vivo pharmacokinetic evaluation

  2025influential citation
• Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier.

  2025cites this paper
• Intranasal Delivery of Paclitaxel-Loaded Ligand Conjugated Polymeric Nanoparticles for Targeted Brain Delivery

  2025cites this paper
• A comparative study between two manufacturing processes for venlafaxine-loaded niosome (Nioven) production: optimization, characterization, pharmacokinetic investigations, depression management, and gene assessment

  2025cites this paper
• Advanced nanoparticle-enabled risperidone delivery for improved therapeutic outcomes of schizophrenia management: a review

  2025cites this paper
• Nanostructured delivery of lavandula essential oils improves safety and neuroprotective efficacy in vivo

  2025cites this paper
• Genistein-loaded nanostructured lipid carriers for intranasal brain delivery: Preparation, optimization, in-vitro evaluation, and amelioration of bioavailability.

  2025cites this paper
• Neurobiological mechanisms and recent advances in drug-based therapeutics in depression.

  2025cites this paper
• QbD-enabled formulation development of imatinib using self-nanoemulsifying drug delivery system in nose-to-brain treatment of Glioblastoma.

  2025cites this paper
• A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery

  2024cites this paper
• Electrospun nanofiber for drug delivery applications: a review

  2024cites this paper
• Nanorobots mediated drug delivery for brain cancer active targeting and controllable therapeutics

  2024cites this paper
• Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders.

  2024cites this paper
• Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study

  2024cites this paper
• Advances in Polysaccharide-Based Formulations for Intranasal Drug Delivery: A Review

  2024cites this paper
• Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.

  2024cites this paper
• Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

  2024influential citation
• Brain Targeting of Venlafaxine via Intranasal Transbilosomes Thermogel for Improved Management of Depressive Disorder.

  2024cites this paper
• MACRO WORLD IN NANO HANDS: NANO REVOLUTIONS IN MEDICINE AND FOOD PROCESSING WITH THE AID OF NANOSENSORS

  2024cites this paper
• Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature

  2024cites this paper
• Nose-to-brain Drug Delivery System: An Emerging Approach to Chemotherapy-induced Cognitive Impairment.

  2024cites this paper
• Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials

  2024cites this paper
• Mefenamic Acid Loaded and TPGS Stabilized Mucoadhesive Nanoemulsion for the Treatment of Alzheimer’s Disease: Development, Optimization, and Brain-Targeted Delivery via Olfactory Pathway

  2024cites this paper
• Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

  2023cites this paper
• Advancements in nanomedicine: Targeted drug delivery systems for cancer treatment

  2023cites this paper
• Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery

  2023cites this paper
• Protective effect of Punica granatum peel extract and its alginate-encapsulated nanoparticles against acrylamide-induced neurotoxicity in rats

  2023cites this paper
• Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

  2023cites this paper
• Comparing and contrasting the use of nanoparticle-assisted drug-delivery of antidepressants to that of the gold standard

  2023cites this paper
• Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders

  2023cites this paper
• Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders

  2023cites this paper
• Confronting antibiotic-resistant pathogens: The drug delivery potential of nanoparticle swords.

  2023cites this paper
• Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers

  2023cites this paper
• Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.

  2023cites this paper
• Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

  2023cites this paper
• DEVELOPMENT OF ABELMASCHUS ESCULENTUS L BASED NANOPARTICLES FOR PERMEABILITY ENHANCEMENT OF RIZATRIPTAN BENZOATE VIA NASOPULMONARY ROUTE

  2023cites this paper
• Recent developments in natural biopolymer based drug delivery systems

  2023cites this paper
• SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION

  2023cites this paper
• Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery.

  2023cites this paper
• An Overview of Nanomaterial Applications in Pharmacology

  2023cites this paper
• How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors

  2023cites this paper
• TYPES AND APPLICATION OF PHARMACEUTICAL NANOTECHNOLOGY: A REVIEW

  2023cites this paper
• Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation

  2023cites this paper
• Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs

  2023cites this paper
• Cancer nanomedicine: a review of nano-therapeutics and challenges ahead

  2023cites this paper
• Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience

  2023cites this paper
• Glyceryl behenate-based solid lipid nanoparticles as a carrier of haloperidol for nose to brain delivery: formulation development, in-vitro, and in-vivo evaluation

  2022cites this paper
• Intranasal administration of 99mTc-topiramate-loaded phospholipid magnesome potential route for enhanced brain delivery: Characterization, biodistribution, and pharmacokinetic behaviors

  2022cites this paper
• Lipid and Polymeric Nanoparticles: Successful Strategies for Nose-to-Brain Drug Delivery in the Treatment of Depression and Anxiety Disorders

  2022cites this paper
• Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression

  2022cites this paper
• Meta-Analysis: A Convenient Tool for the Choice of Nose-to-Brain Nanocarriers

  2022cites this paper
• Nanogels: Update on the methods of synthesis and applications for cardiovascular and neurological complications

  2022cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• A Review of Non-Invasive Drug Delivery through Respiratory Routes

  2022influential citation
• Optimization and Appraisal of Chitosan-grafted PLGA Nanoparticles for Boosting Pharmacokinetics and Pharmacodynamics effect of Duloxetine HCl using Box-Benkhen Design.

  2022cites this paper
• Preparation of melatonin novel-mucoadhesive nanoemulsion used in the treatment of depression

  2022influential citation
• Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective

  2022cites this paper
• Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art

  2022cites this paper
• Application of mathematical modelling to alginate chitosan polyelectrolyte complexes for the prediction of system behavior with Venlafaxine HCl as a model charged drug

  2022cites this paper
• Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification

  2022cites this paper
• Development and Evaluation of Thermo Triggered in situ Nasal Gel of Selegiline for Depressive Disorders: In vitro, in vivo and ex vivo Characterization

  2022cites this paper
• Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders

  2022cites this paper
• Hard, Soft, and Hard-and-Soft Drug Delivery Carriers Based on CaCO3 and Alginate Biomaterials: Synthesis, Properties, Pharmaceutical Applications

  2022cites this paper
• Thymoquinone-Enriched Naringenin-Loaded Nanostructured Lipid Carrier for Brain Delivery via Nasal Route: In Vitro Prospect and In Vivo Therapeutic Efficacy for the Treatment of Depression

  2022cites this paper
• Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management.

  2022cites this paper
• Sodium alginate as a pharmaceutical excipient: novel applications of a well-known polymer.

  2022cites this paper
• Nanomedicine approaches and strategies for gum-based stealth nanocarriers

  2022cites this paper
• Biosafety and Toxicity of Nanomaterials for the Management of Drug and Gene Delivery

  2021cites this paper
• Augmented Brain Delivery of Cinnarizine Through Nanostructured Lipid Carriers Loaded in situ Gel: in vitro and Pharmacokinetic Evaluation

  2021cites this paper
• Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity

  2021cites this paper
• Natural Biomaterials in Brain Repair: a Focus on Collagen.

  2021cites this paper
• Advances in Nano-Enabled Platforms for the Treatment of Depression

  2021cites this paper
• Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

  2021cites this paper
• Biosynthesized/green-synthesized nanomaterials as potential vehicles for delivery of antibiotics/drugs

  2021cites this paper
• Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study

  2021cites this paper
• Methods to evaluate the toxicity of engineered nanomaterials for biomedical applications: a review

  2021cites this paper
• Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy.

  2021cites this paper
• AN OVERVIEW ON CARRIER MEDIATED NOSE TO BRAIN DRUG DELIVERY SYSTEM

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Applications of direct nose-to-brain drug delivery in medicine and pharmacy

  2021cites this paper
• Alginate-based nanocomposite hydrogels

  2021cites this paper
• Gel-based delivery of neurotherapeutics via naso-brain pathways

  2021cites this paper
• Recent advancement and developments in biomaterial-based nanomedicines, imaging, and cures

  2021cites this paper